Acasti Pharma Inc. (NASDAQ:ACST) has a beta value of 1.18 and has seen 1,772,955 shares traded in the recent trading session. The company, currently valued at $47.37 Million, closed the recent trade at $0.529 per share which meant it lost $0 on the day or -3.99% during that session. The ACST stock price is -482.23% off its 52-week high price of $3.08 and 52.74% above the 52-week low of $0.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.41 Million shares traded. The 3-month trading volume is 2.16 Million shares.
The consensus among analysts is that Acasti Pharma Inc. (ACST) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 5 have rated it as a Hold, with 4 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.16.
Acasti Pharma Inc. (NASDAQ:ACST) trade information
Despite being -6.86% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jun 23 when the ACST stock price touched $0.75 or saw a rise of 31.93%. Year-to-date, Acasti Pharma Inc. shares have moved -79.16%, while the 5-day performance has seen it change -29.2%. Over the past 30 days, the shares of Acasti Pharma Inc. (NASDAQ:ACST) have changed -19.35%. Short interest in the company has seen 381.49 Million shares shorted with days to cover at 176.62.
Wall Street analysts have a consensus price target for the stock at $2.92, which means that the shares’ value could jump 451.98% from current levels. The projected low price target is $1.06 while the price target rests at a high of $7. In that case, then, we find that the current price level is +1223.25% off the targeted high while a plunge would see the stock lose 100.38% from current levels.
Acasti Pharma Inc. (ACST) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +30.3% while over the next 5 years, the company’s earnings are expected to increase by 0%.